Skip to main content

ODYSSEY HIGH FH: Efficacy and Safety of Alirocumab in Patients With Severe Heterozygous Familial Hypercholesterolemia

Publication ,  Conference
Ginsberg, HN; Rader, DJ; Raal, FJ; Guyton, JR; Lorenzato, C; Pordy, R; Baccara-Dinet, MT; Stroes, ES
Published in: CIRCULATION
December 2, 2014

Duke Scholars

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

December 2, 2014

Volume

130

Issue

23

Start / End Page

2119 / 2119

Location

Chicago, IL

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Conference Name

Scientific Sessions of the American-Heart-Association and American-Stroke-Association / Resuscitation Science Symposium

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ginsberg, H. N., Rader, D. J., Raal, F. J., Guyton, J. R., Lorenzato, C., Pordy, R., … Stroes, E. S. (2014). ODYSSEY HIGH FH: Efficacy and Safety of Alirocumab in Patients With Severe Heterozygous Familial Hypercholesterolemia. In CIRCULATION (Vol. 130, pp. 2119–2119). Chicago, IL: LIPPINCOTT WILLIAMS & WILKINS.
Ginsberg, Henry N., Daniel J. Rader, Frederick J. Raal, John R. Guyton, Christelle Lorenzato, Robert Pordy, Marie T. Baccara-Dinet, and Eric S. Stroes. “ODYSSEY HIGH FH: Efficacy and Safety of Alirocumab in Patients With Severe Heterozygous Familial Hypercholesterolemia.” In CIRCULATION, 130:2119–2119. LIPPINCOTT WILLIAMS & WILKINS, 2014.
Ginsberg HN, Rader DJ, Raal FJ, Guyton JR, Lorenzato C, Pordy R, et al. ODYSSEY HIGH FH: Efficacy and Safety of Alirocumab in Patients With Severe Heterozygous Familial Hypercholesterolemia. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2014. p. 2119–2119.
Ginsberg, Henry N., et al. “ODYSSEY HIGH FH: Efficacy and Safety of Alirocumab in Patients With Severe Heterozygous Familial Hypercholesterolemia.” CIRCULATION, vol. 130, no. 23, LIPPINCOTT WILLIAMS & WILKINS, 2014, pp. 2119–2119.
Ginsberg HN, Rader DJ, Raal FJ, Guyton JR, Lorenzato C, Pordy R, Baccara-Dinet MT, Stroes ES. ODYSSEY HIGH FH: Efficacy and Safety of Alirocumab in Patients With Severe Heterozygous Familial Hypercholesterolemia. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2014. p. 2119–2119.

Published In

CIRCULATION

EISSN

1524-4539

ISSN

0009-7322

Publication Date

December 2, 2014

Volume

130

Issue

23

Start / End Page

2119 / 2119

Location

Chicago, IL

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Conference Name

Scientific Sessions of the American-Heart-Association and American-Stroke-Association / Resuscitation Science Symposium

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology